KALA BIO Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from KALA BIO Inc
Access all reports
KALA BIO Inc. (formerly Kala Pharmaceuticals Inc.) is a biopharmaceutical company focused on developing and commercializing innovative treatments for ocular diseases. The company leverages its proprietary AMPPLIFY drug delivery technology, which enhances the penetration of therapeutic agents into target tissues. KALA BIO’s product portfolio includes treatments for conditions such as dry eye disease, ocular inflammation, and other front-of-the-eye disorders. The company is headquartered in Arlington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
KALA
Country
🇺🇸 United States